Beyond survival: new study examines hidden side effects of anal cancer treatment

NCT ID NCT07296237

Recruiting now Knowledge-focused Sponsor: Aarhus University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This observational study follows 80 women treated with chemoradiotherapy for anal cancer to understand how radiation affects their vaginal and sexual health. Participants will have a gynecological exam, complete questionnaires about quality of life and sexual health, and allow researchers to analyze their radiation scans. The goal is to link radiation dose to vaginal problems and improve future support for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better prevent, detect, and treat vaginal and sexual problems after radiotherapy, improving quality of life for future patients.
What could go wrong: This is an observational study with only 80 participants, so results may not apply to all women. It does not test a new treatment, so it won't directly change care yet.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anal carcinoma anus neoplasm physiological sexual disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANAL CANCER

Contacts and locations

Locations

Department of Oncology Aarhus University Hospital (AUH)
RECRUITING

Aarhus, 8200, Denmark
Department of Oncology Vejle Hospital, University Hospital of Southern Denmark
RECRUITING

Vejle, 7100, Denmark
Department of Oncology, Herlev and Gentofte Hospital
RECRUITING

Herlev, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.